Tolebrutinib is a potent, selective, oral and brain-penetrant inhibitor of Bruton tyrosine kinase (BTK), with IC50 values of 0. 4 nM in Ramos B cells and 0.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1971920-73-6
PCI-32765 (Racemate)
pharmaceutical raw material
Rilzabrutinib, (Z)-
pharmaceutical raw material
Dynastat
pharmaceutical raw material
Tigecycline hydrochloride
pharmaceutical raw material
Mesna
pharmaceutical raw material
Loxapine
pharmaceutical raw material
4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one
KOEUOFPEZFUWRF-LJQANCHMSA-N
C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=NC=C3)N)N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5